713 filings
Page 5 of 36
8-K
bpk8rzzykc0v0sip73
14 Nov 22
Initiation of Phase 1/2a endometrial cancer trial expected in 1Q23; preliminary data expected 4Q23
4:20pm
4
h7xccvbksxk5ieaqs26q
19 Aug 22
Onconova Therapeutics / JACK E STOVER ownership change
5:10pm
4
0y7mx95hndte pl3la
19 Aug 22
Onconova Therapeutics / JAMES J MARINO ownership change
4:59pm
4
6isll88 e7jq
19 Aug 22
Onconova Therapeutics / VIREN MEHTA ownership change
4:57pm
4
vsucib1 5ak9
19 Aug 22
Onconova Therapeutics / Mary Teresa Shoemaker ownership change
4:55pm
4
lpg44ti8c 7lmqh
19 Aug 22
Onconova Therapeutics / JEROME GROOPMAN ownership change
4:54pm
8-K
p0f mmayv
18 Aug 22
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
oj2cyv7
11 Aug 22
Onconova Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
5:25pm
4
qlkgpnt9p82ixy
4 Aug 22
Onconova Therapeutics / Mark Patrick Guerin ownership change
4:38pm
4
7ru0pxz1jdievbquz
4 Aug 22
Onconova Therapeutics / Mark S. MD Gelder ownership change
4:34pm
4
ejz4s89me4 q2hgt1r
4 Aug 22
Onconova Therapeutics / Steven M Fruchtman ownership change
4:30pm
DEFA14A
vocgbhxh
21 Jul 22
Additional proxy soliciting materials
4:35pm
8-K
wzz6ea9
21 Jul 22
Other Events
4:32pm
4
cbx343x95a0rvs3tivo
13 Jun 22
Onconova Therapeutics / Mark Patrick Guerin ownership change
4:03pm
8-K
bhca0ijp692k07x55
13 Jun 22
Onconova Therapeutics Announces Key Management Promotions
8:05am
8-K
4kmraaxv95
11 May 22
Onconova Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update
4:07pm